Androgen treatment prevents diabetes in nonobese diabetic mice.

Androgen treatment prevents diabetes in nonobese diabetic mice.
复制标题

DOI:
10.1084/jem.175.5.1409
复制
发表时间:
1992-05-01
影响因子:
15.3
通讯作者:
FOX, HS
FOX, HS
中科院分区:
医学1区
文献类型:
--
作者:
FOX, HS

文献摘要

参考文献

被引文献

相似文献

非肥胖糖尿病(NOD)小鼠品系为人类自身免疫性糖尿病提供了一个模型系统。这种疾病模型不仅被广泛用于研究糖尿病的病因和发病机制,而且还被用作评估治疗方法的一种手段。在NOD小鼠中,这种疾病从胰岛炎症发展到胰岛破坏和临床糖尿病,在很高比例的雌性小鼠中。在这项研究中,在胰岛炎症发作后开始的雄激素治疗被发现可以预防胰岛破坏和糖尿病,但不会消除雌性NOD小鼠的胰岛炎症。然而,糖尿病可以过继转移到这种激素治疗的接受者身上。雄激素预防疾病的发生可能是由于破坏胰岛所必需的免疫细胞的发育或功能发生了荷尔蒙变化。
The nonobese diabetic (NOD) mouse strain provides a model system for human autoimmune diabetes. This disease model is extensively used not only to examine the etiology and pathogenesis of diabetes, but also as a means to evaluate therapies. In NOD mice, the disease progresses from insulitis to islet destruction and clinical diabetes in a high percentage of female mice. In this study, androgen therapy, begun after the onset of insulitis, was found to prevent islet destruction and diabetes without eliminating the islet inflammation in female NOD mice. However, diabetes can be adoptively transferred into such hormone- treated recipients. The prevention of disease onset by androgen is likely due to the hormonal alteration of the development or function of the immune cells necessary for islet destruction.
DOI: 10.1210/endo-129-3-1382
发表时间: 1991-09-01
期刊: ENDOCRINOLOGY
影响因子: 4.8
作者:
FITZPATRICK, F;LEPAULT, F;DARDENNE, M
通讯作者: DARDENNE, M
DOI: 10.1038/348639a0
发表时间: 1990-12-13
期刊: NATURE
影响因子: 64.8
作者:
HUTCHINGS, P;ROSEN, H;COOKE, A
通讯作者: COOKE, A
DOI: 10.1007/bf00454884
发表时间: 1986-04-01
期刊: DIABETOLOGIA
影响因子: 8.2
作者:
MORI, Y;SUKO, M;IKEDA, Y
通讯作者: IKEDA, Y
DOI: 10.2337/diabetes.35.8.855
发表时间: 1986-08-01
期刊: DIABETES
影响因子: 7.7
作者:
WICKER, LS;MILLER, BJ;MULLEN, Y
通讯作者: MULLEN, Y
DOI: 10.1084/jem.147.6.1568
发表时间: 1978-06-01
期刊: The Journal of experimental medicine
影响因子: --
作者:
Roubinian JR;Talal N;Greenspan JS;Goodman JR;Siiteri PK
通讯作者: Siiteri PK